FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to medicinal agents, namely, to a novel medicinal agent possessing hypolipidemic effect and representing molecular complex of simvastatin with β-glycyrrhizic acid in the mole ratio simvastatin : β-glycyrrhizic acid= 1:(1-4). Proposed complex possess higher effectiveness in lower doses that results to reducing toxicity in treatment.
EFFECT: improved and valuable medicinal properties of agent.
3 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
HYPOLIPIDEMIC PREPARATION "ATORVAGLYSIN" | 2008 |
|
RU2396079C1 |
PHARMACEUTICAL COMPOSITION FOR HYPERLIPIDEMIA TREATMENT | 2014 |
|
RU2623876C2 |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERLIPIDEMIA | 2017 |
|
RU2683641C2 |
HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENT | 2007 |
|
RU2372923C2 |
METHOD OF LIPID METABOLIC DISORDER CORRECTION | 2007 |
|
RU2337696C1 |
HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
AGENT WITH HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTION | 2008 |
|
RU2372897C1 |
MEDICINAL SPECIES ELICITING HYPOLIPIDEMIC AND ADAPTOGENIC PROPERTIES | 2000 |
|
RU2171679C1 |
HYPOCHOLESTEROLEMIC AGENT | 1992 |
|
RU2034540C1 |
Authors
Dates
2007-10-27—Published
2006-02-26—Filed